Symbiotec Pharmalab IPO opens today: GMP signals 41% upside — Should you subscribe?

Symbiotec Pharmalab’s Rs 1,757 crore IPO opens August 24, with a Rs 938–988 price band and 41% grey-market premium. The issue combines fresh shares and an OFS, while proceeds will partly repay debt. Its specialised API manufacturing, regulatory approvals and biotechnology capabilities offer inve…